Valley Drug Co. v. Geneva Pharmaceuticals, Inc.: Enlarging the Patent Exclusionary Right Through Hatch-Waxman Settlement Agreements Is Not Per Se Anticompetitive?

Authors

• Stephen Roy Jenkins